HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samuel A Wickline Selected Research

gadolinium diethylene-triamine-pentaacetic acid-bis-oleate

8/2013Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
8/2003Improved molecular imaging contrast agent for detection of human thrombus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samuel A Wickline Research Topics

Disease

34Neoplasms (Cancer)
01/2022 - 09/2003
18Atherosclerosis
01/2019 - 11/2003
14Thrombosis (Thrombus)
11/2021 - 08/2003
12Inflammation (Inflammations)
11/2021 - 09/2008
12Atherosclerotic Plaque (Atheroma)
01/2021 - 12/2004
7Melanoma (Melanoma, Malignant)
01/2020 - 03/2005
7Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 10/2006
6Arthritis (Polyarthritis)
12/2019 - 09/2009
5Hemorrhage
01/2020 - 01/2004
4Acute Kidney Injury (Acute Renal Failure)
01/2022 - 06/2014
4Neoplasm Metastasis (Metastasis)
01/2020 - 09/2003
4Stroke (Strokes)
09/2011 - 08/2003
3Reperfusion Injury
11/2021 - 04/2015
3Vascular System Injuries
01/2018 - 03/2004
3Ischemia
04/2015 - 01/2004
3Rupture
02/2012 - 12/2004
3Nephrogenic Fibrosing Dermopathy
11/2011 - 07/2008
3Myocardial Infarction
06/2009 - 08/2003
2Hypertension (High Blood Pressure)
01/2022 - 05/2004
2Osteoarthritis
12/2021 - 01/2019
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
06/2021 - 10/2013
2Neointima
01/2021 - 05/2008
2Necrotizing Enterocolitis
01/2020 - 01/2019
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
09/2018 - 11/2013
2Carotid Artery Injuries
01/2018 - 11/2013
2Rheumatoid Arthritis
07/2014 - 11/2012
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
05/2014 - 09/2012
2Kidney Diseases (Kidney Disease)
11/2013 - 03/2011
2Breast Neoplasms (Breast Cancer)
01/2013 - 08/2010
2Body Weight (Weight, Body)
11/2012 - 08/2010
2Cardiomyopathies (Cardiomyopathy)
09/2012 - 03/2009
2Fibrosis (Cirrhosis)
09/2012 - 03/2009
2Pathologic Constriction (Stenosis)
09/2011 - 05/2008
2Infarction (Infarctions)
12/2004 - 09/2003
2Atrial Fibrillation
11/2004 - 11/2004
1Chronic Renal Insufficiency
01/2022
1Heterotopic Ossification (Ectopic Ossification)
12/2021
1Knee Injuries (Knee Injury)
12/2021
1Sclerosis
12/2021
1Necrosis
11/2021
1Carcinogenesis
06/2021

Drug/Important Bio-Agent (IBA)

23FluorocarbonsIBA
01/2022 - 02/2005
17Contrast MediaIBA
01/2015 - 08/2003
14Pharmaceutical PreparationsIBA
07/2019 - 12/2005
13Small Interfering RNA (siRNA)IBA
12/2021 - 10/2014
13FibrinIBA
01/2020 - 08/2003
12Peptides (Polypeptides)IBA
01/2020 - 09/2009
8ThrombinFDA Link
11/2021 - 11/2013
7fumagillinIBA
01/2016 - 09/2006
7IntegrinsIBA
01/2014 - 03/2005
6phenylalanyl- prolyl- arginine- chloromethyl ketone (PPACK)IBA
11/2021 - 11/2013
6LipidsIBA
01/2019 - 12/2005
5AntithrombinsIBA
01/2020 - 04/2015
5ProdrugsIBA
01/2016 - 11/2012
5Biomarkers (Surrogate Marker)IBA
02/2012 - 09/2003
5GadoliniumIBA
11/2011 - 02/2005
4CholesterolIBA
01/2018 - 11/2003
4Apolipoproteins E (ApoE)IBA
10/2017 - 09/2009
4LigandsIBA
11/2013 - 08/2008
4Melitten (Melittin)IBA
10/2013 - 09/2009
3Sirolimus (Rapamycin)FDA Link
01/2022 - 05/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 01/2016
3FluorineIBA
01/2018 - 09/2008
3Lipase (Acid Lipase)FDA Link
01/2016 - 11/2012
3perflubron (L 1913)FDA Link
08/2015 - 06/2006
3EpitopesIBA
01/2015 - 09/2003
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2014 - 01/2009
3Liposomes (Liposome)IBA
11/2013 - 02/2005
3MetalsIBA
11/2011 - 07/2008
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2017
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
2OligonucleotidesIBA
07/2019 - 01/2018
2CytokinesIBA
01/2019 - 11/2009
2gadolinium diethylene-triamine-pentaacetic acid-bis-oleateIBA
08/2013 - 08/2003
2DystrophinIBA
09/2012 - 08/2007
2Lanthanoid Series Elements (Lanthanides)IBA
11/2011 - 07/2008
2Biological ProductsIBA
06/2011 - 02/2006
2RhodaminesIBA
06/2011 - 03/2011
2Thromboplastin (Tissue Factor)IBA
02/2006 - 03/2004
2ElastinIBA
05/2004 - 11/2002
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1MacrolidesIBA
01/2022
1SodiumIBA
01/2022
1Epithelial Sodium ChannelsIBA
01/2022
1Angiotensin IIIBA
01/2022
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2022
1PeriostinIBA
12/2021
1Nanoparticle Drug Delivery SystemIBA
06/2021
1Trans-Activators (Trans-Acting Factor)IBA
06/2021
1Etoposide (VP 16)FDA LinkGeneric
06/2021
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
15' Untranslated Regions (5' UTR)IBA
01/2021

Therapy/Procedure

31Therapeutics
01/2022 - 09/2003
3Precision Medicine
01/2015 - 12/2009
3Drug Therapy (Chemotherapy)
01/2014 - 01/2009
2Injections
01/2020 - 10/2014
2Stents
11/2016 - 01/2012
2Intravenous Administration
08/2015 - 11/2010
2Microbubbles
06/2006 - 02/2005